Van der Veken, M.; Brouwers, J.; Ozbey, A.C.; Umehara, K.; Stillhart, C.; Knops, N.; Augustijns, P.; Parrott, N.J.
Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding. Pharmaceutics 2023, 15, 2231.
https://doi.org/10.3390/pharmaceutics15092231
AMA Style
Van der Veken M, Brouwers J, Ozbey AC, Umehara K, Stillhart C, Knops N, Augustijns P, Parrott NJ.
Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding. Pharmaceutics. 2023; 15(9):2231.
https://doi.org/10.3390/pharmaceutics15092231
Chicago/Turabian Style
Van der Veken, Matthias, Joachim Brouwers, Agustos Cetin Ozbey, Kenichi Umehara, Cordula Stillhart, Noël Knops, Patrick Augustijns, and Neil John Parrott.
2023. "Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding" Pharmaceutics 15, no. 9: 2231.
https://doi.org/10.3390/pharmaceutics15092231
APA Style
Van der Veken, M., Brouwers, J., Ozbey, A. C., Umehara, K., Stillhart, C., Knops, N., Augustijns, P., & Parrott, N. J.
(2023). Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding. Pharmaceutics, 15(9), 2231.
https://doi.org/10.3390/pharmaceutics15092231